Several studies have observed elevated BACE1 serum levels in individuals with early-stage AD who exhibited a better cognitive function and subsequently progressed to dementia, indicating the potential of serum BACE1 levels as an early predictor of cognitive decline [31,35,36]. Here, BACE1 is linked to Alzheimer disease.